Bausch Health
BHC
#4653
Rank
HK$16.52 B
Marketcap
HK$44.54
Share price
-1.04%
Change (1 day)
-21.49%
Change (1 year)
Bausch Health is a Canadian company that researches, develops and produces pharmaceuticals and markets patented drugs, generics and non-prescription drugs in the areas of dermatology and ophthalmology.

EPS for Bausch Health (BHC)

EPS in 2025 (TTM): HK$7.57

According to Bausch Health 's latest financial reports the company's current EPS (TTM) is HK$7.58. In 2024 the company made an earnings per share (EPS) of -HK$0.94 an increase over its 2023 EPS that were of -HK$12.66.

EPS history for Bausch Health from 2012 to 2025

Annual EPS

Year EPS Change
2025 (TTM)HK$7.57-907.38%
2024-HK$0.94-92.59%
2023-HK$12.66160.89%
2022-HK$4.85-76.64%
2021-HK$20.7768.45%
2020-HK$12.33-68.91%
2019-HK$39.66-57.11%
2018-HK$92.47-272.22%
2017HK$53.70-199.29%
2016-HK$54.08798.7%
2015-HK$6.02-128.31%
2014HK$21.26-204.62%
2013-HK$20.32602.7%
2012-HK$2.89

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
OPKO Health
OPK
-HK$1.88-124.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
-HK$7.42-197.94%๐Ÿ‡บ๐Ÿ‡ธ USA